Caitong International Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Buy
14,245
+13,814
+3,205% +$300K 0.05% 310
2025
Q4
$9.47K Sell
431
-1,774
-80% -$32K ﹤0.01% 1150
2025
Q3
$26.8K Buy
2,205
+1,470
+200% +$19.9K 0.02% 551
2025
Q2
$13.7K Buy
735
+716
+3,768% +$14.2K 0.01% 618
2025
Q1
$364 Buy
+19
New +$556 ﹤0.01% 1840

Other funds holding TNDM

Caitong International Asset Management's TNDM Position: Q1 2026 in Review

Caitong International Asset Management increased its Tandem Diabetes Care (TNDM) stake by 3,205% in Q1 2026, buying an estimated $300K and bringing the position to 14,245 shares worth $273K. The position accounts for 0.05% of the portfolio, ranked #310.

Caitong International Asset Management first reported a position in TNDM in Q1 2025 and has held it in 5 quarters since. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Caitong International Asset Management held 14,245 shares of Tandem Diabetes Care worth $273K as of Q1 2026.
  • Caitong International Asset Management bought 13,814 Tandem Diabetes Care shares in Q1 2026, an estimated $300K.
  • Tandem Diabetes Care made up 0.05% of Caitong International Asset Management's portfolio in Q1 2026, its #310 holding.
  • Caitong International Asset Management first reported a position in Tandem Diabetes Care in Q1 2025 and has held it in 5 quarters since.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.